Invention Grant
- Patent Title: ADAM6 mice
-
Application No.: US16059871Application Date: 2018-08-09
-
Publication No.: US10577430B2Publication Date: 2020-03-03
- Inventor: Lynn Macdonald , Sean Stevens , Andrew J. Murphy , Margaret Karow
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Choate, Hall & Stewart LLP
- Agent Brenda Herschbach Jarrell; Stephanie L. Schonewald
- Main IPC: C12N5/10
- IPC: C12N5/10 ; C07K16/40 ; C07K16/28 ; C07K16/46 ; C12N9/64 ; C12N15/85 ; B60H1/32 ; A01K67/027 ; C07K16/22

Abstract:
Mice are provided that comprise a reduction or deletion of ADAM6 activity from an endogenous ADAM6 locus, or that lack an endogenous locus encoding a mouse ADAM6 protein, wherein the mice comprise a sequence encoding an ADAM6 or ortholog or homolog or fragment thereof that is functional in a male mouse. In one embodiment, the sequence is an ectopic ADAM6 sequence or a sequence that confers upon a male mouse the ability to generate offspring by mating. Mice and cells with genetically modified immunoglobulin heavy chain loci that comprise an ectopic nucleotide sequence encoding a mouse ADAM6 or functional fragment or homolog or ortholog thereof are also provided.
Public/Granted literature
- US20180346598A1 ADAM6 MICE Public/Granted day:2018-12-06
Information query